AstraZeneca to use part of Russian Covid vaccine in trials
11 December 2020, 10.59
Detta är en artikel från AFP.
Pharmaceutical giant AstraZeneca's Russian branch said Friday it would use part of Russia's homemade Sputnik V vaccine in further clinical trials.
"Today we announce a clinical trial programme to assess safety and immunogenicity of a combination of AZD1222, developed by AstraZeneca and Oxford University, and Sputnik V, developed by Russian Gamaleya Research institute" AstraZeneca said in a statement published on its website in English and Russian.
acl/emg/ach
ASTRAZENECA
Artikeln återges av Omni enligt avtal med upphovsrättsinnehavaren.
